• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通人群和骨关节炎患者中上消化道出血危险因素的患病率。

Prevalence of upper gastrointestinal bleeding risk factors among the general population and osteoarthritis patients.

作者信息

Kim Sang Hyuck, Yun Jae Moon, Chang Chong Bum, Piao Heng, Yu Su Jong, Shin Dong Wook

机构信息

Sang Hyuck Kim, Jae Moon Yun, Dong Wook Shin, Department of Family Medicine, Seoul National University Hospital, Seoul 03080, South Korea.

出版信息

World J Gastroenterol. 2016 Dec 28;22(48):10643-10652. doi: 10.3748/wjg.v22.i48.10643.

DOI:10.3748/wjg.v22.i48.10643
PMID:28082817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5192276/
Abstract

AIM

To assess the prevalence of possible risk factors of upper gastrointestinal bleeding (UGIB) and their age-group specific trend among the general population and osteoarthritis patients.

METHODS

We utilized data from the National Health Insurance Service that included claims data and results of the national health check-up program. Comorbid conditions (peptic ulcer, diabetes, liver disease, chronic renal failure, and gastroesophageal reflux disease), concomitant drugs (aspirin, clopidogrel, cilostazol, non-steroidal anti-inflammatory drugs, steroid, anticoagulants, and SSRI), personal habits (smoking, and alcohol consumption) were considered as possible UGIB risk factors. We randomly imputed the prevalence of infection in the data considering the age-specific prevalence of () infection in Korea. The prevalence of various UGIB risk factors and the age-group specific trend of the prevalence were identified. Prevalence was compared between osteoarthritis patients and others.

RESULTS

A total of 801926 subjects (93855 osteoarthritis patients) aged 20 and above were included. The prevalence of individual and concurrent multiple risk factors became higher as the age increased. The prevalence of each comorbid condition and concomitant drug were higher in osteoarthritis patients. Thirty-five point zero two percent of the overall population and 68.50% of osteoarthritis patients had at least one or more risk factors of UGIB. The prevalence of individual and concurrent multiple risk factors in younger age groups were also substantial. Furthermore, when personal habits (smoking, and alcohol consumption) and infection were included, the prevalence of concurrent multiple risk factors increased greatly even in younger age groups.

CONCLUSION

Prevalence of UGIB risk factors was high in elderly population, but was also considerable in younger population. Patient with osteoarthritis was at higher UGIB risk than those without osteoarthritis. Physicians should consider individualized risk assessment regardless of age when prescribing drugs or performing procedures that may increase the risk of UGIB, and take necessary measures to reduce modifiable risk factors such as eradication or lifestyle counseling.

摘要

目的

评估上消化道出血(UGIB)可能的危险因素在普通人群和骨关节炎患者中的患病率及其年龄组特异性趋势。

方法

我们利用了来自国民健康保险服务的数据,其中包括理赔数据和全国健康检查计划的结果。合并症(消化性溃疡、糖尿病、肝病、慢性肾衰竭和胃食管反流病)、伴随用药(阿司匹林、氯吡格雷、西洛他唑、非甾体抗炎药、类固醇、抗凝剂和选择性5-羟色胺再摄取抑制剂)、个人习惯(吸烟和饮酒)被视为可能的UGIB危险因素。我们根据韩国()感染的年龄特异性患病率,对数据中的感染患病率进行随机推算。确定了各种UGIB危险因素的患病率及其年龄组特异性趋势。比较了骨关节炎患者与其他患者的患病率。

结果

共纳入801926名20岁及以上的受试者(93855名骨关节炎患者)。个体和并发多种危险因素的患病率随年龄增长而升高。骨关节炎患者中每种合并症和伴随用药的患病率更高。总体人群的35.02%和骨关节炎患者的68.50%至少有一个或多个UGIB危险因素。年轻年龄组中个体和并发多种危险因素的患病率也相当高。此外,当纳入个人习惯(吸烟和饮酒)和()感染时,即使在年轻年龄组中,并发多种危险因素的患病率也大幅增加。

结论

UGIB危险因素在老年人群中的患病率较高,但在年轻人群中也相当可观。骨关节炎患者发生UGIB的风险高于无骨关节炎的患者。医生在开具可能增加UGIB风险的药物或进行相关操作时,应不分年龄考虑个体化风险评估,并采取必要措施降低可改变的危险因素,如()根除或生活方式咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d25/5192276/fed678d8c5d8/WJG-22-10643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d25/5192276/01961bf85380/WJG-22-10643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d25/5192276/fed678d8c5d8/WJG-22-10643-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d25/5192276/01961bf85380/WJG-22-10643-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d25/5192276/fed678d8c5d8/WJG-22-10643-g002.jpg

相似文献

1
Prevalence of upper gastrointestinal bleeding risk factors among the general population and osteoarthritis patients.普通人群和骨关节炎患者中上消化道出血危险因素的患病率。
World J Gastroenterol. 2016 Dec 28;22(48):10643-10652. doi: 10.3748/wjg.v22.i48.10643.
2
Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.幽门螺杆菌感染对服用非甾体抗炎药、抗血小板药物、抗凝剂、皮质类固醇和选择性 5-羟色胺再摄取抑制剂的患者发生消化性溃疡出血的风险的影响。
Aliment Pharmacol Ther. 2018 Jun;47(11):1464-1471. doi: 10.1111/apt.14652. Epub 2018 Apr 14.
3
Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.基于人群中阿司匹林、质子泵抑制剂和幽门螺杆菌根除治疗处方的变化,上、下消化道出血住院的趋势:上、下消化道出血的趋势。
United European Gastroenterol J. 2021 Jun;9(5):543-551. doi: 10.1002/ueg2.12067. Epub 2021 May 6.
4
Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.氯吡格雷使用者胃肠道出血的风险因素:一项全国范围内基于人群的研究。
Aliment Pharmacol Ther. 2013 Nov;38(9):1119-28. doi: 10.1111/apt.12483. Epub 2013 Sep 15.
5
Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.幽门螺杆菌与十二指肠溃疡出血:感染率及非甾体抗炎药的作用
Scand J Gastroenterol. 2001 Jul;36(7):717-24. doi: 10.1080/003655201300191978.
6
High prevalence of ulcer bleeding risk factors in dual antiplatelet-treated patients after percutaneous coronary intervention.经皮冠状动脉介入治疗后接受双联抗血小板治疗患者溃疡出血危险因素的高患病率。
Dan Med J. 2015 Jun;62(6).
7
Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding.上消化道出血的流行病学及危险因素
Gastrointest Endosc Clin N Am. 2015 Jul;25(3):415-28. doi: 10.1016/j.giec.2015.02.010.
8
Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.幽门螺杆菌、非甾体抗炎药和抗血小板药物相关的消化性溃疡出血危险因素。
Scand J Gastroenterol. 2011 Nov;46(11):1295-301. doi: 10.3109/00365521.2011.605468. Epub 2011 Aug 5.
9
[The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].[中国南方经皮冠状动脉介入治疗后接受双联抗血小板治疗患者上消化道出血的发生率、临床特征及危险因素]
Zhonghua Nei Ke Za Zhi. 2016 Jun;55(6):445-50. doi: 10.3760/cma.j.issn.0578-1426.2016.06.009.
10
Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.阿司匹林使用者上消化道出血的风险因素:一项基于人群队列研究的旧问题与新发现。
J Formos Med Assoc. 2019 May;118(5):939-944. doi: 10.1016/j.jfma.2018.10.007. Epub 2018 Oct 23.

引用本文的文献

1
Frailty and risk of gastrointestinal bleeding: a prospective cohort study based on UK biobank.衰弱与胃肠道出血风险:一项基于英国生物银行的前瞻性队列研究。
Front Public Health. 2025 Jul 4;13:1625869. doi: 10.3389/fpubh.2025.1625869. eCollection 2025.
2
Hospital-based prevalence and predictors of upper gastrointestinal bleeding in Northern Uganda: a retrospective cross-sectional study.乌干达北部地区以医院为基础的上消化道出血患病率及预测因素:一项回顾性横断面研究。
BMC Gastroenterol. 2025 Jul 1;25(1):475. doi: 10.1186/s12876-025-04072-x.
3
Comparison of the Quick Sequential Organ Failure Assessment (qSOFA) Score With the Glasgow-Blatchford Score (GBS) and Rockall Score (RS) in Predicting the Need for Intensive Care Among Acute Upper Gastrointestinal Bleeding Patients.

本文引用的文献

1
Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.系统评价与网络荟萃分析:预防 NSAID 相关胃肠道毒性的策略的比较有效性和安全性。
Aliment Pharmacol Ther. 2016 Jun;43(12):1262-75. doi: 10.1111/apt.13642. Epub 2016 Apr 28.
2
The Effect of Asthma Clinical Guideline for Adults on Inhaled Corticosteroids PrescriptionTrend: A Quasi-Experimental Study.成人哮喘临床指南对吸入性糖皮质激素处方趋势的影响:一项准实验研究。
J Korean Med Sci. 2015 Aug;30(8):1048-54. doi: 10.3346/jkms.2015.30.8.1048. Epub 2015 Jul 15.
3
快速序贯器官衰竭评估(qSOFA)评分与格拉斯哥-布拉奇福德评分(GBS)及罗卡尔评分(RS)在预测急性上消化道出血患者重症监护需求方面的比较
Cureus. 2025 Mar 15;17(3):e80613. doi: 10.7759/cureus.80613. eCollection 2025 Mar.
4
Aetiology and Feasibility of Endoscopic Interventions for Massive Upper Gastrointestinal Bleeding in Makurdi, North-Central Nigeria.尼日利亚中北部马库尔迪大量上消化道出血的内镜干预病因及可行性
J West Afr Coll Surg. 2025 Apr-Jun;15(2):191-196. doi: 10.4103/jwas.jwas_22_24. Epub 2024 Sep 2.
5
Long-Term Outcomes following Acute Upper Gastrointestinal Bleeding Remain Poor: A Single-Center Comparison over Two Distinct Time Periods within the Last 15 Years in Finland.急性上消化道出血的长期预后仍然较差:芬兰过去15年中两个不同时间段的单中心比较
Visc Med. 2024 Feb;40(1):30-38. doi: 10.1159/000535061. Epub 2024 Jan 2.
6
Risk factors for major gastrointestinal bleeding in the general population in Finland.芬兰普通人群中主要胃肠道出血的风险因素。
World J Gastroenterol. 2022 May 14;28(18):2008-2020. doi: 10.3748/wjg.v28.i18.2008.
7
Clinical features of obscure gastrointestinal bleeding undergoing capsule endoscopy: A retrospective cohort study.胶囊内镜检查不明原因胃肠道出血的临床特征:一项回顾性队列研究。
PLoS One. 2022 Mar 24;17(3):e0265903. doi: 10.1371/journal.pone.0265903. eCollection 2022.
8
Characterization of potentially inappropriate medication prescriptions for the elderly in primary care and hospital settings.基层医疗和医院环境中老年人潜在不适当用药处方的特征分析。
J Family Med Prim Care. 2021 Aug;10(8):3111-3115. doi: 10.4103/jfmpc.jfmpc_271_21. Epub 2021 Aug 27.
9
Older age and diclofenac are associated with increased risk of upper gastrointestinal bleeding in gout patients.老年和双氯芬酸与痛风患者上消化道出血风险增加有关。
PeerJ. 2021 May 20;9:e11468. doi: 10.7717/peerj.11468. eCollection 2021.
10
Is There a Role for Tranexamic Acid in Upper GI Bleeding? A Systematic Review and Meta-Analysis.氨甲环酸在上消化道出血中是否有作用?一项系统评价和荟萃分析。
Surg Res Pract. 2021 Jan 29;2021:8876991. doi: 10.1155/2021/8876991. eCollection 2021.
Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding.
上消化道出血的流行病学及危险因素
Gastrointest Endosc Clin N Am. 2015 Jul;25(3):415-28. doi: 10.1016/j.giec.2015.02.010.
4
The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi Arabia.塞来昔布与非甾体抗炎药加质子泵抑制剂治疗沙特阿拉伯骨关节炎的成本效益
Health Econ Rev. 2015 Dec;5(1):53. doi: 10.1186/s13561-015-0053-7. Epub 2015 Jun 11.
5
Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.服用非甾体抗炎药、抗血小板药物或抗凝剂的患者上消化道和下消化道出血的风险。
Clin Gastroenterol Hepatol. 2015 May;13(5):906-12.e2. doi: 10.1016/j.cgh.2014.11.007. Epub 2014 Nov 14.
6
Epidemiology and diagnosis of acute nonvariceal upper gastrointestinal bleeding.急性非静脉曲张性上消化道出血的流行病学与诊断
Gastroenterol Clin North Am. 2014 Dec;43(4):643-63. doi: 10.1016/j.gtc.2014.08.001. Epub 2014 Sep 12.
7
Evidence-based review of gastrointestinal bleeding in the chronic kidney disease patient.慢性肾病患者胃肠道出血的循证综述
Semin Dial. 2015 Jan-Feb;28(1):68-74. doi: 10.1111/sdi.12301. Epub 2014 Sep 12.
8
Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis.选择性 5-羟色胺再摄取抑制剂联合或不联合非甾体抗炎药使用时上消化道出血的风险:系统评价和荟萃分析。
Am J Gastroenterol. 2014 Jun;109(6):811-9. doi: 10.1038/ajg.2014.82. Epub 2014 Apr 29.
9
Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.幽门螺杆菌阴性、非甾体抗炎药阴性的亚洲特发性溃疡
World J Gastroenterol. 2014 Jan 21;20(3):706-13. doi: 10.3748/wjg.v20.i3.706.
10
Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance.预防上消化道出血:当前的争议和临床指导。
Ther Adv Chronic Dis. 2013 Sep;4(5):206-22. doi: 10.1177/2040622313492188.